All News

CAR-X

Charles River’s Memphis Facility Approved to Manufacture Vertex’s CASGEVY™
20 December 2023
Charles River’s Memphis Facility Approved to Manufacture Vertex’s CASGEVY™
Charles River has achieved a
ViroCell Partners with UCL to Accelerate Research in Preventing Relapse in Childhood Blood Cancer
13 December 2023
ViroCell Partners with UCL to Accelerate Research in Preventing Relapse in Childhood Blood Cancer
ViroCell and UCL partner to
FDA Investigating ‘Serious Risk’ of Secondary Malignancy Linked to BCMA- or CD19-Directed CAR-T Immunotherapies
29 November 2023
FDA Investigating ‘Serious Risk’ of Secondary Malignancy Linked to BCMA- or CD19-Directed CAR-T Immunotherapies
FDA investigates T cell malignancy
Arcellx and Gilead’s Kite Further Expands Their Strategic Partnership
16 November 2023
Arcellx and Gilead’s Kite Further Expands Their Strategic Partnership
Kite has decided to exercise
POPULAR NEWS ITEMS
Image
14 May 2024

Intensified extracellular vesicle production in fixed-bed bioreactors: Discover low-footprint, automated solutions for low-cost extracellular vesicles manufacturing

Image
8 April 2024

Women in Advanced Therapies Global 2024, Virtual Event

Image
25 March 2024

RNA Connect 2025, South Carolina

20 Years of Advanced Therapies with Claudia Zylberberg: a Community Sense of Time & Value for the Industry
31 October 2023
20 Years of Advanced Therapies with Claudia Zylberberg: a Community Sense of Time & Value for the Industry
Claudia Zylberberg, Founder/Chair of Board/Senior
20 Years of Advanced Therapies with Pascal Touchon: a Perennial Story of Resilience, to Reality
23 October 2023
20 Years of Advanced Therapies with Pascal Touchon: a Perennial Story of Resilience, to Reality
Pascal Touchon, President and CEO
Broken String Bioscience Closes $15M Series A Funding Round
19 September 2023
Broken String Bioscience Closes $15M Series A Funding Round
Broken String Biosciences has announced
FDA Delays the Review of Iovance’s BLA Treatment of Advanced Melanoma
15 September 2023
FDA Delays the Review of Iovance’s BLA Treatment of Advanced Melanoma
The FDA has notified Iovance
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

Intensified extracellular vesicle production in fixed-bed bioreactors: Discover low-footprint, automated solutions for low-cost extracellular vesicles manufacturing

Image

Women in Advanced Therapies Global 2024, Virtual Event

Image

RNA Connect 2025, South Carolina